StarBem Mais

Partnership objectives

The main purpose of StarBem Mais is comprehensive patient care, through the actions that compose this integrated platform. Built on five pillars – information, education, support, access and solutions – StarBem Mais brings together all Sanofi initiatives for people with diabetes in Brazil, providing a wide range of services.

The project is a consolidated channel to improve the quality of life of patients with diabetes and strengthen doctor-patient relationships. The virtual community informs and establishes discussions among diabetes patients to identify unmet needs for treatment of the disease and other concerns.

If no preventive measures are implemented, it is estimated that 592 million people will have diabetes worldwide by 2035. If no preventive measures are implemented, it is estimated that 592 million people will have diabetes worldwide by 2035. Copyright Sanofi

What are the health needs and challenges?

According to the International Diabetes Federation, nearly one in two (46%) of the 415 million adults living with diabetes are unaware that they have the condition. Most of these cases are type 2 diabetes.

In Brazil, according to Sociedade Brasileira de Diabetes (Brazilian Diabetes Society), there are more than 13 million people living with diabetes, which represents 6.9% of the population - and that number is growing. In some cases, the diagnosis is delayed, which can be a factor for complications.

Sanofi Diabetes has provided several services for patients with diabetes over a long period of time. In 2012, the company decided to consolidate all initiatives towards the same goal, putting the patient at the very heart of an online platform called "StarBem Mais Program".

Description of partnership activities and how they address needs and challenges

StarBem Mais provides a wide range of services that go beyond the access to products. Some of these activities include:

  • Educational visit of instructors intended to explain diabetes basics, the importance of self-monitoring, how to use insulin and the delivery of a kit with information materials;
  • A recently launched physician/patient Portal and App, which aim to provide an educational and motivational journey to help patients achieve adherence and persistence to their treatment, with contacts with diabetes educators. SMS and e-mails with motivational support content, nutritional tips and reminders are also sent;
  • Two dedicated call centers composed of a trained health team: one for the patient enrollment and the other aimed at assisting patients with information on products and treatment. Call centers respond to an average of 12,000 calls/month;
  • A network of 4,500 accredited pharmacies;
  • A tiered-pricing program with possible treatment discounts (insulin and medications for hypertension and cholesterol, glucose meters and strips). 

By late 2016, it’s estimated more than 500,000 patients had been benefited from StarBem Mais Platform, among them 53,000 benefited from discounted medication.

Partnership information

Company(ies) Sanofi

Partner(s) Accredited Pharmacies

Type of Partner(s) Other Business

Therapeutic Focus Non-Communicable Diseases

Disease(s) Diabetes

Program Type(s) Availability of Treatment - Differential Pricing, Health System Infrastructure - Outreach & Medical Services, Prevention Programs - Awareness & Outreach

Targeted Population(s) General population, Patients in needs of treatment

Region(s) Latin America & Caribbean

Number of Countries 1

Country(ies) Brazil

Start Date 2013

More information StarBem website

Anticipated completion date Ongoing